Default: The Lancet Diabetes and Endocrinology

ISSN: 2213-8587

Journal Home

Journal Guideline

The Lancet Diabetes and Endocrinology Q1 Unclaimed

Elsevier BV Netherlands
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The Lancet Diabetes and Endocrinology is a journal indexed in SJR in Endocrinology and Endocrinology, Diabetes and Metabolism with an H index of 114. It has an SJR impact factor of 8,596 and it has a best quartile of Q1. It has an SJR impact factor of 8,596.

The Lancet Diabetes and Endocrinology focuses its scope in these topics and keywords: diabetes, type, patients, disease, change, digestto, drugscorrection, drugssglt, early, hypopituitarism, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Metrics

The Lancet Diabetes and Endocrinology

8,596

SJR Impact factor

114

H Index

218

Total Docs (Last Year)

632

Total Docs (3 years)

4977

Total Refs

5391

Total Cites (3 years)

220

Citable Docs (3 years)

8,05

Cites/Doc (2 years)

22,83

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


diabetes, type, patients, disease, change, digestto, drugscorrection, drugssglt, early, hypopituitarism, doctor, endocrinol, ensuring, essentials, genes, health, incidentalomas, inhibition, differencepcsk, diagnosis, advances, advancing, affordable, againeffects, antiepileptic, article, cardiovascular, dapagliflozin, dataneuroendocrine, declare, development, diabeteshow, diabeteskaushik, diabetic,



Best articles by citations

Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial

View more

An artistic awakening

View more

Endocrinology in focus: photo competition 2015

View more

I'll have what they're having

View more

The Look AHEAD study: a missed opportunity

View more

The Look AHEAD study: a missed opportunity -Authors' Reply

View more

The Look AHEAD study: a missed opportunity -Editors' Reply

View more

Body language

View more

Marching for endometriosis awareness

View more

Tumoral calcinosis in chronic renal failure

View more

Excess deaths in women with type 1 diabetes: time to act

View more

Screening for differentiated thyroid cancer in selected populations

View more
SHOW MORE ARTICLES

Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial

View more

The proliferation of irrational metformin fixed-dose combinations in India

View more

New traditions in Middle Eastern hospitality

View more

Association between 25-hydroxyvitamin D and type 2 diabetes

View more

Metyrapone stimulation test to diagnose central adrenal insufficiency

View more

Effectiveness of an mHealth intervention to improve the cardiometabolic profile of people with prehypertension in low-resource urban settings in Latin America: a randomised controlled trial

View more

Endemic diabetes in the world's poorest people

View more

Weight loss: slow and steady does not win the race

View more

Use of national data sources in diabetes epidemiology

View more

ALTITUDE: defining a ceiling for blockade of the renin-angiotensin system?

View more

Dying for a good night's sleep

View more

Leptin: 20 years later

View more

FAQS